Aldevron News: Corporate News

Aldevron to Divest its Antibody Discovery Unit

Aldevron, a leading manufacturer of plasmid DNA, proteins and mRNA, today announced the sale of its Germany based antibody discovery businessBrian Walters, current president of the business unit and longtime employee of Aldevronled a group of investors to purchase the business for an undisclosed amount. The transaction is effective immediately.  

Read More

Kevin Ballinger to Assume CEO Role at Aldevron; Michael Chambers to become Executive Chairman

Attracting one of med-tech’s most accomplished executives, Aldevron has named Kevin Ballinger as Chief Executive Officer, effective July 13, 2020. Aldevron’s co-founder, Michael Chambers, has been named Executive Chairman of the board. Chambers initiated the transition to allow him to focus on innovation, corporate strategy and working with clients and industry thought leaders to develop new technologies that enable genetic medicine. Ballinger will assume day-to-day operational leadership of Aldevron, facilitating the company’s rapid growth.

Read More

Aldevron Breaks Ground on 14-Acre Campus Expansion

Fargo, N.D., based company increasing capacity to better serve
rapidly growing biotech industry

Aldevron officially broke ground on its 14-acre campus expansion at its global headquarters in Fargo, North Dakota, August 19. Three buildings are planned, with construction of its next GMP manufacturing facility starting first.

Read More

Aldevron Names Lance Monilaws as Director of Industrial Project Management

Lance Monilaws of Aldevron has been promoted as its Director of Industrial Project Management. In his position, Monilaws will direct large capital projects with emphasis in facility expansion, renovation and campus planning. He will also manage various operational initiatives and strategies, including but not limited to construction and industrial technology.

Read More